Nascent Biotech Gestione
Gestione criteri di controllo 4/4
Nascent Biotech's CEO is Sean Carrick, appointed in Mar 2015, has a tenure of 9.67 years. total yearly compensation is $252.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 13.39% of the company’s shares, worth $1.85M. The average tenure of the management team and the board of directors is 9.7 years and 9.3 years respectively.
Informazioni chiave
Sean Carrick
Amministratore delegato
US$252.0k
Compenso totale
| Percentuale dello stipendio del CEO | 100.0% |
| Mandato del CEO | 9.7yrs |
| Proprietà del CEO | 13.4% |
| Durata media del management | 9.7yrs |
| Durata media del Consiglio di amministrazione | 9.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$2m |
| Mar 31 2024 | US$252k | US$252k | -US$2m |
| Dec 31 2023 | n/a | n/a | -US$2m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | US$252k | US$252k | -US$3m |
| Dec 31 2022 | n/a | n/a | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$1m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | US$252k | US$252k | -US$470k |
| Dec 31 2021 | n/a | n/a | US$319k |
| Sep 30 2021 | n/a | n/a | -US$998k |
| Jun 30 2021 | n/a | n/a | -US$1m |
| Mar 31 2021 | US$352k | US$252k | -US$959k |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | US$323k | US$250k | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | US$262k | US$186k | -US$1m |
| Dec 31 2018 | n/a | n/a | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$2m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | US$151k | US$151k | -US$2m |
Compensazione vs Mercato: Sean's total compensation ($USD252.00K) is below average for companies of similar size in the US market ($USD655.65K).
Compensazione vs guadagni: Sean's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Sean Carrick (56 yo)
9.7yrs
Mandato
US$252,000
Compensazione
Mr. Sean Carrick has been the President of Nascent Biotech, Inc. since March 9, 2015 and serves as its Chief Executive Officer and Secretary. Mr. Carrick has been Director of Nascent Biotech, Inc. since Ju...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 9.7yrs | US$252.00k | 13.39% $ 1.9m | |
| CFO, Chief Accounting Officer & Director | 10.5yrs | US$180.00k | 6.95% $ 960.4k | |
| Founder | no data | US$43.00k | Nessun dato | |
| Chief Medical Consultant | 4.4yrs | Nessun dato | Nessun dato |
9.7yrs
Durata media
72yo
Età media
Gestione esperta: NBIO's management team is seasoned and experienced (9.7 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 10.3yrs | US$252.00k | 13.39% $ 1.9m | |
| CFO, Chief Accounting Officer & Director | 10.3yrs | US$180.00k | 6.95% $ 960.4k | |
| Member of Scientific Advisory Board | 9.3yrs | Nessun dato | Nessun dato | |
| Independent Director | 8.6yrs | US$20.00k | 1.05% $ 145.7k | |
| Member of Scientific Advisory Board | 1.9yrs | Nessun dato | Nessun dato |
9.3yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: NBIO's board of directors are considered experienced (9.3 years average tenure).